These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35606091)

  • 1. Hybrid closed-loop system improves glycaemic control in young people with type 1 diabetes compared with conventional management.
    Holdstock V; Singh N
    Arch Dis Child Educ Pract Ed; 2023 Apr; 108(2):144. PubMed ID: 35606091
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 3. Real-world outcomes with different technology modalities in type 1 diabetes.
    Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training and Support for Hybrid Closed-Loop Therapy.
    Boughton CK; Hartnell S; Allen JM; Fuchs J; Hovorka R
    J Diabetes Sci Technol; 2022 Jan; 16(1):218-223. PubMed ID: 32914648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closed-Loop System Improves Glycemic Control but Not Hypoglycemia for Young Children With Type 1 Diabetes Mellitus.
    Am Fam Physician; 2022 Jul; 106(1):99A-99B. PubMed ID: 35839352
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic Contract in Adolescents Using Hybrid Closed Loop System.
    Tornese G; Carletti C; Barbiero C; Faleschini E; Barbi E
    J Diabetes Sci Technol; 2021 Mar; 15(2):528-529. PubMed ID: 32830533
    [No Abstract]   [Full Text] [Related]  

  • 7. Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series.
    Daly A; Hartnell S; Boughton CK; Evans M
    J Diabetes Sci Technol; 2021 Nov; 15(6):1216-1223. PubMed ID: 34378426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study.
    Seget S; Jarosz-Chobot P; Ochab A; Polanska J; Rusak E; Witoszek P; Chobot A
    Front Endocrinol (Lausanne); 2022; 13():1036808. PubMed ID: 36303875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial.
    Elbarbary NS; Ismail EAR
    Diabetes Res Clin Pract; 2022 Sep; 191():110045. PubMed ID: 35987309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-loop insulin delivery in type 1 diabetes.
    Thabit H; Hovorka R
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):105-17. PubMed ID: 22575409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Multiple Daily Injections to Hybrid Closed-Loop System in Ten Days, Utilizing a Structured Initiation Protocol.
    Petrovski G; Al Khalaf F; Campbell J; Fisher H; Umer F; Hussain K
    J Diabetes Sci Technol; 2020 May; 14(3):689-690. PubMed ID: 31876178
    [No Abstract]   [Full Text] [Related]  

  • 12. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
    Bergenstal RM; Garg S; Weinzimer SA; Buckingham BA; Bode BW; Tamborlane WV; Kaufman FR
    JAMA; 2016 Oct; 316(13):1407-1408. PubMed ID: 27629148
    [No Abstract]   [Full Text] [Related]  

  • 14. Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
    Bally L; Thabit H; Kojzar H; Mader JK; Qerimi-Hyseni J; Hartnell S; Tauschmann M; Allen JM; Wilinska ME; Pieber TR; Evans ML; Hovorka R
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):261-270. PubMed ID: 28094136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
    Fuchs J; Allen JM; Boughton CK; Wilinska ME; Thankamony A; de Beaufort C; Campbell F; Yong J; Froehlich-Reiterer E; Mader JK; Hofer SE; Kapellen TM; Rami-Merhar B; Tauschmann M; Hood K; Kimbell B; Lawton J; Roze S; Sibayan J; Cohen N; Hovorka R;
    BMJ Open; 2021 Feb; 11(2):e042790. PubMed ID: 33579766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes technology management traps in a pediatric patient: not all that glitters is gold.
    Piccini B; Casalini E; Macucci C; Toni S
    Acta Diabetol; 2022 Jan; 59(1):137-141. PubMed ID: 34417888
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased proportion of time in hybrid closed-loop "Auto Mode" is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump.
    Duffus SH; Ta'ani ZA; Slaughter JC; Niswender KD; Gregory JM
    Diabetes Obes Metab; 2020 Apr; 22(4):688-693. PubMed ID: 31709736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
    N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.
    Tauschmann M; Allen JM; Wilinska ME; Thabit H; Stewart Z; Cheng P; Kollman C; Acerini CL; Dunger DB; Hovorka R
    Diabetes Care; 2016 Jul; 39(7):1168-74. PubMed ID: 26740634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative.
    Noor N; Kamboj MK; Triolo T; Polsky S; McDonough RJ; Demeterco-Berggren C; Jacobsen L; Sonabend R; Ebekozien O; DeSalvo DJ
    Diabetes Care; 2022 Aug; 45(8):e118-e119. PubMed ID: 35708494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.